Nathaniel Weygant
机构: Professor, Fujian University of Traditional Chinese Medicine
每年引用次数
引用次数
引用: 2,005
H-指数: 28
I10-指数 : 34
出版物: 113
Kai-Yen Peng1, Shih-Sheng Jiang2, Yu-Wei Lee1, Fang-Yu Tsai2, Chia-Chi Chang1, 3, Li-Tzong Chen2, 4, 5 and B. Linju Yen 1
Nathaniel Weygant , Tae Il Kim , Shing Yau Tam
Cancer Stem Cells in the Gastrointestinal Tumor Microenvironment 4 -4
2022
Research Article RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
Jiannan Yao , Wanchun Zang , Yang Ge , Nathaniel Weygant
2018
Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells
P Chandrakesan , J Panneerselvam , D Qu , N Weygant
Journal of carcinogenesis & mutagenesis 7 ( 2) 1 -8
22
2016
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug-resistance, Stemness, and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer
D Qu , N Weygant , P Chandrakesan , R May
PANCREAS 48 ( 10) 1510 -1511
2019
DCLK1 Polarized M2 Macrophages Inhibit CD8+ T-cell Activity
P Chandrakesan , J Panneerselvam , R May , K Pitts
PANCREAS 48 ( 10) 1410 -1411
2019
Alternative Splice Variants of DCLK1 in Pancreatic Tumor Cells Coordinates Macrophage Polarization and an Immunosuppressive Phenotype
P Chandrakesan , N Weygant , J Panneerselvam , N Ali
PANCREAS 47 ( 10) 1377 -1378
2018
Dclk1 a Novel Therapeutic Target for the Reprogramming of PDAC TME
P Chandrakesan , N Ali , R May , N Weygant
PANCREAS 46 ( 10) 1393 -1393
2017
Overexpression of DCLK1 in Pancreatic Cancer Cells Increases Chemo-resistance via Activating KRAS/PI3K/MTOR Signaling Pathway
D Qu , N Weygant , J Yao , WL Berry
PANCREAS 46 ( 10) 1427 -1428
2017
Overexpression of DCLK1 in Pancreatic Cancer Cells Supports Tumorigenesis, Invasiveness, and Stemness
D Qu , N Weygant , W Berry , R May
PANCREAS 44 ( 8) 1409 -1409
2015
Serum DCLK1 Levels are Elevated in Early Stage Pancreatic Cancer Patients
D Qu , P Chandrakesan , J Johnson , N Weygant
PANCREAS 43 ( 8) 1402 -1402
2014
The Absence of Pancreatic Ductal Dclk1 Entirely Reverses the Progression of Cerulein-Induced ADM in Mice
R May , D Qu , N Weygant , S Sureban
PANCREAS 43 ( 8) 1389 -1390
2014
A Kinase Inhibitor Specific for DCLK1 Demonstrates Therapeutic Potential Against Human Pancreatic Adenocarcinoma Cells
D Qu , N Weygant , W Berry , R May
PANCREAS 42 ( 8) 1377 -1378
2013
Regulation of Angiogenic Factors by DCLK1 in Pancreatic Cancer
SM Sureban , R May , N Weygant , D Qu
PANCREAS 42 ( 8) 1383 -1384
2013